You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

MUSTARGEN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Mustargen, and what generic alternatives are available?

Mustargen is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in MUSTARGEN is mechlorethamine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the mechlorethamine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MUSTARGEN?
  • What are the global sales for MUSTARGEN?
  • What is Average Wholesale Price for MUSTARGEN?
Drug patent expirations by year for MUSTARGEN
Drug Prices for MUSTARGEN

See drug prices for MUSTARGEN

Recent Clinical Trials for MUSTARGEN

Identify potential brand extensions & 505(b)(2) entrants

Eastern Cooperative Oncology GroupPhase 3
National Cancer Institute (NCI)Phase 3

See all MUSTARGEN clinical trials

US Patents and Regulatory Information for MUSTARGEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare MUSTARGEN mechlorethamine hydrochloride INJECTABLE;INJECTION 006695-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.